Cervical and lung cancer are more common in poor people while rates of breast cancer and melanoma are higher in the wealthy.
A detailed analysis of the incidence of these four different kinds of cancer, carried out on more than 300,000 English cancer patients and published today in the open access journal BMC Cancer, describes the effects of socioeconomic group, region and age.
Normal-weight women who carry out lots of vigorous exercise are approximately 30% less likely to develop breast cancer than those who don’t exercise vigorously.
A study of more than thirty thousand postmenopausal American women, reported in BioMed Central’s open access journal Breast Cancer Research, has revealed that a sedentary lifestyle can be a risk factor for the disease – even in women who are not overweight.
Herceptin, an expensive drug which improves the chances of women battling an aggressive type of breast cancer, will be available for free from the beginning of next year, The Sunday Times has learnt.
The tender for the purchase of this treatment will be issued in the Government Gazette on Friday, Health Parliamentary Secretary Joe Cassar confirmed when contacted by the newspaper.
ScienceDaily (Apr. 8, 2008) — Green tea is high in the antioxidant EGCG (epigallocatechin-3- gallate) which helps prevent the body’s cells from becoming damaged and prematurely aged. Studies have suggested that the combination of green tea and EGCG may also be beneficial by providing protection against certain types of cancers, including breast cancer. A new study conducted by researchers at the University of Mississippi researchers now finds that consuming EGCG significantly inhibits breast tumor growth in female mice.
According to a recent report by the World Health Organization, exposure to asbestos fibers at the workplace is one of the leading causes of occupational disease worldwide.
Gene patents are now used to halt research, prevent medical testing and keep vital information from you and your doctor. Gene patents slow the pace of medical advance on deadly diseases. And they raise costs exorbitantly: a test for breast cancer that could be done for $1,000 now costs $3,000.
